Assessment of Psoas Muscle Index in Middle-Aged Type 2 Diabetes Patients: Impact of Insulin Therapy on Sarcopenia.
Ismail TaskentBunyamin EceSonay AydinPublished in: Tomography (Ann Arbor, Mich.) (2024)
Insulin therapy in T2DM patients, regardless of age or disease duration, positively impacts muscle mass, highlighting its potential in preserving muscular health and advocating for tailored treatment strategies in T2DM management.
Keyphrases
- type diabetes
- end stage renal disease
- newly diagnosed
- glycemic control
- ejection fraction
- chronic kidney disease
- middle aged
- healthcare
- public health
- skeletal muscle
- cardiovascular disease
- mental health
- metabolic syndrome
- insulin resistance
- adipose tissue
- cell therapy
- social media
- resistance training
- replacement therapy